1. Home
  2. ATRO vs ABCL Comparison

ATRO vs ABCL Comparison

Compare ATRO & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRO
  • ABCL
  • Stock Information
  • Founded
  • ATRO 1968
  • ABCL 2012
  • Country
  • ATRO United States
  • ABCL Canada
  • Employees
  • ATRO N/A
  • ABCL N/A
  • Industry
  • ATRO Military/Government/Technical
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATRO Industrials
  • ABCL Health Care
  • Exchange
  • ATRO Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • ATRO 1.2B
  • ABCL 1.1B
  • IPO Year
  • ATRO N/A
  • ABCL 2020
  • Fundamental
  • Price
  • ATRO $39.89
  • ABCL $4.47
  • Analyst Decision
  • ATRO Strong Buy
  • ABCL Strong Buy
  • Analyst Count
  • ATRO 1
  • ABCL 5
  • Target Price
  • ATRO $49.00
  • ABCL $8.00
  • AVG Volume (30 Days)
  • ATRO 1.0M
  • ABCL 3.9M
  • Earning Date
  • ATRO 11-05-2025
  • ABCL 11-03-2025
  • Dividend Yield
  • ATRO N/A
  • ABCL N/A
  • EPS Growth
  • ATRO N/A
  • ABCL N/A
  • EPS
  • ATRO N/A
  • ABCL N/A
  • Revenue
  • ATRO $822,852,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • ATRO $9.05
  • ABCL $15.60
  • Revenue Next Year
  • ATRO $6.88
  • ABCL $65.70
  • P/E Ratio
  • ATRO N/A
  • ABCL N/A
  • Revenue Growth
  • ATRO 10.99
  • ABCL N/A
  • 52 Week Low
  • ATRO $14.13
  • ABCL $1.89
  • 52 Week High
  • ATRO $46.61
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • ATRO 58.68
  • ABCL 55.07
  • Support Level
  • ATRO $39.24
  • ABCL $4.09
  • Resistance Level
  • ATRO $46.61
  • ABCL $4.28
  • Average True Range (ATR)
  • ATRO 2.09
  • ABCL 0.25
  • MACD
  • ATRO 0.37
  • ABCL 0.02
  • Stochastic Oscillator
  • ATRO 39.08
  • ABCL 73.57

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: